IL6 and congenital rubella syndrome: Several effective therapies for managing severe fatal CRS after CAR-T therapy include: hemofiltration, fractionated CAR-T infusion, antibody-based immunotherapy pretreatment, GM-CSF blocking, IL-1 and IL-6 inhibition, and therapeutic plasma exchange [142].